|
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay |
|
|
|
Titel: |
Validation of cancer-type-dependent benefit from immune checkpoint blockade in TMB-H tumors identified by the FoundationOne CDx assay |
Auteur: |
McGrail, D.J. PiliƩ, P.G. Rashid, N.U. Voorwerk, L. Slagter, M. Kok, M. Jonasch, E. Khasraw, M. Heimberger, A.B. Ueno, N.T. Ferrarotto, R. Chang, J.T. Lin, S.-Y. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 33 () nr. 11 pagina's 1204-1206 |
Jaar: |
2022 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|